HeiQ Calls for Textile Industry's United Effort by Offering Proprietary "Viroblock" to CHT, JINTEX and Piedmont

Image
Press Trust of India ZURICH
Last Updated : Apr 29 2020 | 4:54 PM IST

/ -- Swiss textile innovator HeiQ announces that it offers proprietary formulation technology HeiQ Viroblock NPJ03 to its peers, calling for a united effort to help fight the global pandemic.

Striving to help advance the global fight against coronavirus on textiles, HeiQ recently launched HeiQ Viroblock NPJ03, an antimicrobial textile treatment proven effective against human coronavirus (229E) in face mask testing, with over 99.99% reduction of virus infectivity in minutes, and lasts least 30 washes. Since its launch the company has been utilizing its full capacity of 145 tons per day in its four manufacturing sites.

In his interview with CNN, HeiQ Group CEO Carlo Centonze expressed the urgent need to maximize the impact of the international textile industry in fighting the global pandemic, even if that meant sharing HeiQ's proprietary technology. HeiQ has since offered to share HeiQ Viroblock to textile industry peers via a free licence, sharing the formula and manufacturing protocol to permit its manufacture and commercialization to meet the regulatory compliance and performance requirement. Licensees will be required to test their treated fabrics with licensed third-party testing institutes to establish efficacy and quality as per HeiQ's standards. Use of the "HeiQ Viroblock" trademark will require trademark authorization directly by HeiQ to ensure truthful and compliant claims.

"We must act now to produce textiles that are more resistant to pathogens. The textile industry must work together in a united effort to reduce the risk and speed of textile-related contamination and transmission," says Carlo Centonze, HeiQ Group CEO. "That is the only way to re-open our economies swiftly and maintain jobs in the textile industry," he added.

Ralf Kattanek, Group Vice President Textiles of CHT Group said, "We believe by using CHT's textile expertise and production capacities globally that we can play a key role in mitigating the impact for the healthcare workers and our industry partners by maximizing our reach swiftly."
David Juang, Chairman of JINTEX Group adds, "We want to show leadership in taking decisive action in a coordinated effort."
Full version of this press release: https://heiq.com/news/
About HeiQ
About CHT
About JINTEX
About Piedmont

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Apr 29 2020 | 4:54 PM IST

Next Story